Bacteria in humans, food and animals continue to show resistance to the most widely used antimicrobials, says the latest report on antimicrobial resistance in zoonotic bacteria in Europe. Resistance to ciprofloxacin, an antimicrobial that is critically important for the treatment of human infections, continues to be very high in Campylobacter, thus reducing the options for effective treatment of severe foodborne infections. In addition, multi-drug resistant Salmonella bacteria continue to spread across Europe.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.
The antimicrobial resistance data on zoonotic and indicator bacteria in 2013, submitted by 28 EU Member States, were jointly analysed by EFSA and ECDC.
This report shows joint analysis by ECDC and EFSA of antimicrobial resistance data among zoonotic and indicator bacteria submitted by 26 European Union Member States in 2012.
This protocol for harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter from human isolates aims to increase the quality and comparability of antimicrobial resistance data collected at the EU level from different Member States. It is primarily targeted to the National Public Health Reference Laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
Bacteria such as Salmonella and Campylobacter, some of the most common causes of food-borne infections, showed significant resistance to common antimicrobials, according to the newly published EFSA-ECDC European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2012.
This report describes a country mission undertaken by ECDC in 2011 to Latvia, to address issues relating to HIV, STI and hepatitis B and C identified by the Latvian government.